In contrast, lower expression of ZMYND8 is linked to breast, prostate, and nasopharyngeal cancers, and ZMYND8 exerts tumor-suppressive effects on breast and prostate cancers [8,9,24,25]. This evidence concerns the gene ZMYND8 and prostate carcinoma.